Physician-scientists at Stanford Neuroscience are actively involved
in ground-breaking research to better the lives of individuals with
neurological disorders. We work collaboratively to translate these
research innovations into leading-edge treatments for patients around
the world.
We are hopeful about identifying future treatments and care
strategies through investigating the underlying mechanisms of
neurological disease. Some of the clinical trials we offer our
patients are not available anywhere else in the world.
Stanford neurologists have come another step closer to identifying
blood factors that might reverse neurological decline. This
breakthrough is one that may change the lives of millions of people
worldwide who endure the challenges of neurological disorders. Many of
these disorders still have no treatment. We are driven to change
that.
Our experts work closely with Stanford’s world-renowned researchers
in other fields, including behavioral sciences, neurobiology,
psychiatry, molecular and cellular physiology, and bioengineering.
This synergy has led to an incomparable range of advanced diagnostic
and treatment options for patients.
The department has developed leading clinical care centers for dementia,
epilepsy,
stroke,
multiple
sclerosis and other neuromuscular
disorders, movement
disorders, and headache,
in addition to three programs that are relatively rare in neurology
departments – autonomic
disorders, complex intraoperative monitoring, and neuro-oncology.
Stanford’s neurosurgeons and research scientists are driving forward
the most innovative technologies in neurosurgery – from leading-edge
research and clinical trials to widespread implementation of our
innovations. We are advancing the way many neurological diseases or
injuries are treated, including stroke,
Parkinson’s
disease, moyamoya,
epilepsy,
and brain tumors.
We are restoring function through deep brain
stimulation, focused ultrasound, CyberKnife
radiosurgery, cellular transplantation, stem cell transplantation,
and brain-computer interfaces. Significant innovations focused on
minimally invasive surgery techniques, from endovascular to
microscopic surgery, were developed at Stanford.
Our experts remain at the forefront of the most exciting clinical
trials that are not commonly available at other centers. We are
testing vaccines for glioblastomas,
developing new anti-tumor CD47 therapies, and creating stem cell
transplantation therapies to treat the brain following stroke.
As our technological innovations advance, so does our need to
rigorously demonstrate that the treatments are effective. This is why
we created a Division of Outcomes Research to help us achieve our goal
of providing effective, evidence-based neurosurgery treatments.